ARCH Venture Management, LLC Diversified Active

CIK: 0001274403 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: May 14, 2019

Total Value ($000): $103,550 (100.0% shares, 0.0% debt)

Holdings (6)

— RUBIUS THERAPEUTICS INC 45.8%

Value ($000) $47,392 Shares 2,618,351 Est. Cost $16.08 Unrealized —

KURA KURA ONCOLOGY INC 25.7%

Value ($000) $26,649 Shares 1,606,307 Est. Cost $13.25 Unrealized +16.3%

FATE FATE THERAPEUTICS INC 21.6%

Value ($000) $22,370 Shares 1,273,190 Est. Cost $13.94 Unrealized +13.2%

— CHIASMA INC 6.0%

Value ($000) $6,223 Shares 1,196,776 Est. Cost $3.11 Unrealized —

— BELLEROPHON THERAPEUTICS, INC 0.6%

Value ($000) $631 Shares 965,660 Est. Cost $0.80 Unrealized —

— ACHAOGEN INC 0.3%

Value ($000) $285 Shares 624,544 Est. Cost $1.23 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	RUBIUS THERAPEUTICS INC	2,618,351	$47,392	45.8%	$16.08	—	COM	78116T103
KURA	KURA ONCOLOGY INC	1,606,307	$26,649	25.7%	$13.25	+16.3%	COM	50127T109
FATE	FATE THERAPEUTICS INC	1,273,190	$22,370	21.6%	$13.94	+13.2%	COM	31189P102
—	CHIASMA INC	1,196,776	$6,223	6.0%	$3.11	—	COM	16706W102
—	BELLEROPHON THERAPEUTICS, INC	965,660	$631	0.6%	$0.80	—	COM	078771102
—	ACHAOGEN INC	624,544	$285	0.3%	$1.23	—	COM	004449104